Continue your journey online

Keynote Speaker: The importance of embedding sustainability within your overall organizational strategy Companies need to understand the long-term value of sustainability, not only to ensure a positive impact on society and the environment, but also to grow their businesses

The pharmaceutical landscape is undergoing a dynamic transformation, driven by technological advancements and a renewed perspective on collaborations. Central to this transformation is the role of CDMOs as strategic partners. In addition to providing access to the cutting-edge technologies th...

Cell & Gene Therapies bring a promising future for many serious and rare disease patients. However, manufacturing these treatments represent a lot of challenges and can represent a barrier to the development and thus limiting broader access to these promising cures.
Seqens, with the ongoing acquisit...

The core health benefits of probiotics are supporting gut health and immune health, which are gradually recognized by mass consumers, especially after the pandemic period and education. In addition, due to the diverse concepts of “Gut-X Axis”, probiotics are also considered and explored as alternative solu...

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators, and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain.
This can only be achieved ...

Join us as we dive into the key considerations of choosing a CDMO as a biotech, and how to select the perfect partner: • Establishing a pre-partner checklist of what you need (regulation, manufacturing technology, and logistics) to avoid unnecessary costly measures • Why understanding your molecul...

Networked care is scaling up as an effective model of care for rare diseases, with prevention, diagnosis, care, and treatment administered locally, informed by the body of knowledge and expertise from the whole network.
• How a collaborative network can bring about an effective learning process, ...

• How CDMO organizations can be designed differently from the traditional way, and how additional value can be realized • How the Lean/Agile principles can be applied to organization design • How the expectations from CDMOs are evolving.

mRNA vaccines helped us through the COVID-19 pandemic — but they could also help defend against many other infectious diseases. Join Moderna to understand how mRNA can play a key role in future therapies.
• Learnings from the COVID-19 vaccine and translating mRNA technology to other therapy areas...

An overview of current microbiome studies and the potential for improving health outcomes by starting with the gut:
• Understanding current challenges in clinical development to help create a strong framework • Why does Europe need to take account of US-based studies to help create regulatory...

Join Frances Zipp, where she will delve into the latest innovations and developments in drug manufacturing and how the industry can embrace 4.0

A global leader with over 40 years of biologics manufacturing experience. Decades of partnerships with highly regarded pharmaceutical and biotechnology companies around the world, paired with scalable cGMP-compliant facilities and industry-leading technology, mean we have the knowledge and tools to provide...

Outlining collaborative and communication strategies that can help enhance an outsourcing partnership The importance of information sharing between client and vendor for effective situation response Case study showcase of a successfully implemented partnership strategy

After years of investment in R&D, pharmaceutical companies have brought to the market a growing number of new therapies based on mRNA or viral vector technology, which require storage at freezing temperatures. Deep cold storage poses great challenges to the primary packaging container. This session will ...

Blow-fill-seal (BFS) technology is being explored for one-dose presentations of vaccines and other biologics, providing a continuous, automated process that can lower manufacturing costs, increasing access for patients worldwide. Other BFS benefits for biologics developers include enhanced automated p...

The changing healthcare system increases the necessity for a more patient-centric approach. Join patient advocate Heidi Floyd, where she will delve into how pharma can create a robust patient-centric supply chain, such as:
• Developing greater collaboration and communication between suppliers, ma...

Evolution of the pharmaceutical industry in the UAE and the significant increase in the number of factories and diversity of products. • Strategies put in place and collaboration between the government and the private sector • Attraction of Innovation and medicines of the future. • Opportunities ...

Ferrar’s objective is to lead change towards more sustainable production by adopting criteria and commitments that minimize the environmental footprint of its containers and packaging
For this, it has designed the Sustainable Packaging Model, with the participation of Anthesis Lavola.
The Mo...

Improving the patient experience in clinical studies is essential for encouraging participant engagement, retention, and satisfaction, ultimately leading to more reliable and meaningful research outcomes. Join our panel on for insights into improving patient outcomes in clinical studies • View ‘The Pat...

Though viral vectors are used extensively in cell and gene therapy, the challenges of manufacturing such complex biologics at industrial scale is still a limitation to its broader use.
Dr. Ayuso will speak about how upstream and downstream process optimization using design of experiments (DOE), a p...

Join the discussion with our thought leaders from across pharma to discuss what’s next for the sector in terms of sustainability and the logistics of creating a circular economy.
Building a circular economy through collaboration
Setting targets and defining your sustainability strategy ...

• The Covid-19 Pandemic forced us to learn new ways of collaborating and innovating to solve a global crisis - what can we learn and leverage from this experience as we adapt to a new normal? • Amazing scientific development and break-throughs are evolving faster than ever, with new advanced tre...

Highly Potent APIs are a rapidly growing segment of the global pharmaceutical industry, and they are acquiring a significant relevance into the development space. The importance to understand the challenges around development of High Potency Oral solids formulations, are the key to ensure a right scale-up ...

Remote Patient Monitoring has been growing steadily since COVID-19 as it allows healthcare providers to monitor patient health from the comfort of their home. Discover how a drug delivery device company can harness the power of digital technology in transforming patient care and creating opportunity for ph...

A global leader with over 40 years of biologics manufacturing experience. Decades of partnerships with highly regarded pharmaceutical and biotechnology companies around the world, paired with scalable cGMP-compliant facilities and industry-leading technology, mean we have the knowledge and tools to provide...

GELITA introduces its latest innovation EASYSEAL®: a pharmaceutical grade Softgel gelatin, that improves capsule seams and helps Softgel manufacturers to • Significantly reduce leaking Softgels • Manufacture with higher machine speed • Increase Yield • Reduce production costs • Enable fil...

>R&D Review – What are the Therapies of the Future?

BSI – set the scene of the challenge of manufacturing antibiotics and the environment - 3 mins
Centrient – what we have done so far to invest in mitigating environmental threat?– 5 mins BSI – One Health approach towards setting industry standard and certification for combatting antibiotics dischar...

In a world where patients are more than ever actively and digitally involved in their health, they demand experiences that are not inferior to the preferred experiences offered in other parts of their lives. This profoundly impacts packaging, clinical trial enrolment, and data capturing… Christophe highli...

Join our panel of experts to explore the tangible opportunities AI brings to pharma manufacturing: • Improving batch manufacturing processes • Efficient quality assurance and regulatory compliance • Defining the role of chatbots and the potential for improving training and compliance standards in...

Join Asklepios BioPharmaceutical's former CEO Shelia Ann Mikhail, where she will Set the Scene for the latest innovations and developments affecting the Biomanufacturing Landscape

The pharmaceutical industry faces significant challenges in bringing new drugs to market due to the complexities of the R&D process. These challenges include high costs, lengthy development timelines, and a low success rate. In response to these challenges, a new approach to R&D has emerged: R&D 4.0. qq...

We finished off the day by learning to understand the latest trends and developments in the CDMO space, and strategies for developing successful partnerships. • Market trends and developments in the CDMO space • Reviewing your in-house capabilities to determine what services you need • Best pract...

Digital transformation is a key area of development in pharma, but potential can be limited by regulatory roadblocks, a talent gap and integration complexities. Join our experts to gain insights into overcoming challenges and implementing the latest technologies: • Becoming tech-led, not led by technol...

Alcohol hangover symptoms are unpleasant, and once they develop, they are difficult to alleviate, adversely affecting daily activities. The dietary supplement Alcofiltrum has been clinically proven to effectively and proactively alleviate the severity of these symptoms, making it helpful for individuals wh...

OXYCAPT
• OXYCAPT Multilayer Plastic Vial for Biologics and Gene/Cell Therapy • High Oxygen, CO2 and UV Barrier suitable for Biologics and Gene/Cell Therapy • Extremely Low Inorganic Extractables Suitable for Biologics and Gene/Cell Therapy • New Container Closure Integrity (CCI) Data ...

Technology is playing an ever-greater role in life sciences, and new ways of working in automation and supply chain. Join our panel of experts where they will delve into what is required in developing a new standard for manufacturing quality • Focus on business and patient outcomes over te...

With a science-based target set for 2030, Merck has launched a Supplier Decarbonization Program to lower the greenhouse gas emissions along its supply chain. Creating transparency of the emissions associated with the products Merck purchases is key to understanding how this reduction is progressing. Compan...

• Ensuring quality and compliance in bio-manufacturing • Closing gaps in development data prior to the first GMP production • Adjusting manufacturing processes throughout the course of a site-to-site transfer • Fulfilling special requirements on container closure systems for biologics • ...

Reactions involving metal catalysis, both homogeneous as well as heterogenous catalysis and chiral organic synthesis are always subjects of great interest in organic synthesis. All these reactions involve the usage of metals such as, Ni, Pd, Pt, Rh, Ru etc.. Not only the cost of these metals but also the e...

• The Covid-19 Pandemic forced us to learn new ways of collaborating and innovating to solve a global crisis - what can we learn and leverage from this experience as we adapt to a 'new normal'?
Amazing scientific development and break-throughs are evolving faster than ever, with new advanced ...

TBC

Gerresheimer is a system solution provider with a unique portfolio of pharmaceutical packaging solutions including drug delivery systems. High product quality in standardized format are key factors to enable an efficient and reliable fill & finish process. Gerresheimer offers a comprehensive vial portfolio...

Plastic solutions in healthcare are vital. Though carbon emissions and wastefulness are inherent in today’s linear economy, changes are needed across the pharma and healthcare industry. To manage this in a safe way, strong value-chain collaboration is needed.
Key talking points include:
A...

This session offers guidance on innovative patient-centric approaches to packaging design.
• Outlining the importance of primary packaging and the need for patient involvement • How involving patients in early development can help improve compliance and product durability from the design process...